While the edit was observed at ~50% in control brains, it was absent in a matched Alzheimer’s disease model expressing pathogenic Tau proteins (Figure 7—figure supplement 2D), suggesting pathogenic Tau expression alters Arc1 editing. This evidence concerns the gene MAPT and Alzheimer disease.